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Forward genetic screens using chemical mutagens have been successful in defining the function of thousands of genes in
eukaryotic model organisms. The main drawback of this strategy is the time-consuming identification of the molecular
lesions causative of the phenotypes of interest. With whole-genome sequencing (WGS), it is now possible to sequence
hundreds of strains, but determining which mutations are causative among thousands of polymorphisms remains challenging. We have sequenced 394 mutant strains, generated in a chemical mutagenesis screen, for essential genes on the
Drosophila X chromosome and describe strategies to reduce the number of candidate mutations from an average of ~3500
to 35 single-nucleotide variants per chromosome. By combining WGS with a rough mapping method based on large
duplications, we were able to map 274 (~70%) mutations. We show that these mutations are causative, using small 80-kb
duplications that rescue lethality. Hence, our findings demonstrate that combining rough mapping with WGS dramatically
expands the toolkit necessary for assigning function to genes.
[Supplemental material is available for this article.]
Systematically defining the function of genes remains one of the
most challenging endeavors in biological sciences. Several large
forward and reverse genetic efforts have been initiated in mice to
address this issue (Justice et al. 1999; Clark et al. 2004; Bradley et al.
2012; White et al. 2013). However, Caenorhabditis elegans and
Drosophila melanogaster are still the most coveted systems to perform systematic functional annotation of genes required for development, nervous system function, organogenesis, metabolism,
etc. (Venken et al. 2011). To this end, three main approaches are
typically used: RNA interference (RNAi), transposon hopping, and
chemical mutagenesis. Each of these methods has advantages as
well as drawbacks (Mohr et al. 2010; Venken et al. 2011). Chemical
mutagens like EMS (ethyl methanesulfonate) have the major advantage of being unbiased and often permit the generation of allelic
series. However, mapping the causative mutations using traditional
techniques is tedious and time consuming (Venken et al. 2011).
The limitations of chemical mutagenesis, however, can be
partially overcome by using low concentrations of mutagen to
reduce the mutagenic load, thereby reducing the generation of
second site mutations that can modify the phenotype of interest
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and confound mapping efforts. Moreover, if a method can be developed to efficiently map hundreds of mutations in a relatively
short time, a major hurdle would be overcome. Currently, mutations are mapped in Drosophila using duplications (Cook et al.
2010; Venken et al. 2010), deficiencies (Parks et al. 2004; Cook et al.
2012), recombination mapping based on visible markers, singlenucleotide variations (SNVs) (Berger et al. 2001; Hoskins et al.
2001), and/or P-elements (Zhai et al. 2003). The process typically
takes several months, depending on the availability of genetic
tools, and the methods are not easily scalable to large sets. Hence,
a majority of mutations, generated in prior forward genetic EMSmutagenesis screens, remain unassigned to a gene, even though
cursory phenotypic studies have been carried out. Thus, highthroughput strategies, facilitating identification of the causative
mutations, are highly desirable.
With the advent of whole-genome sequencing (WGS) (Sarin
et al. 2008, 2010; Blumenstiel et al. 2009) and the reduction in cost
of sequencing an entire genome (less than $500 per Drosophila

Ó 2014 Haelterman et al. This article is distributed exclusively by Cold Spring
Harbor Laboratory Press for the first six months after the full-issue publication
date (see http://genome.cshlp.org/site/misc/terms.xhtml). After six months, it
is available under a Creative Commons License (Attribution-NonCommercial
4.0 International), as described at http://creativecommons.org/licenses/by-nc/
4.0/.

24:1707–1718 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/14; www.genome.org

Genome Research
www.genome.org

1707

Haelterman et al.
genome at 303 coverage) (Hobert 2010), it is now possible to sequence an entire collection of mutant strains. In principle, comparing mutant and wild-type genome sequences should allow for
the unambiguous identification of phenotype-causing mutations.
However, natural sequence variation between chromosomes from
different strains makes it challenging to determine causative mutations. For example, sequencing of 120 wild-type flies revealed
one SNV per 25 nucleotides (Mackay et al. 2012). This corresponds
to nearly 1 million polymorphisms for the X chromosome, which
is 22.4 Mb and contains 2194 genes (http://www.ncbi.nlm.nih.
gov/mapview/stats/BuildStats.cgi?taxid=7227&build=9&ver=
4&chrm=X). Moreover, even flies that share similar genetic backgrounds exhibit numerous SNVs (Blumenstiel et al. 2009; Keightley
et al. 2009). Hence, WGS does not provide a direct solution to the
problem of mapping causative mutations.
Thus far, several proof-of-principle studies, each applying
different approaches to successfully map a chemically induced
mutation using WGS, have been documented in the literature
(Sarin et al. 2008, 2010; Blumenstiel et al. 2009; Zhang et al. 2009;
Earley and Jones 2011; Fairfield et al. 2011; Andrews et al. 2012;
Bull et al. 2013). In general, a subset of SNVs is first removed based
on assay-specific criteria upon which some form of mapping is
performed to reduce the number of candidate mutations. For instance, Leshchiner et al. (2012) designed an algorithm that identifies
SNVs in regions of homozygosity when one combines meiotic
mapping with WGS (Leshchiner et al. 2012). Here, every mutant
strain is allowed to recombine for several generations with a wildtype strain of different genetic background, upon which a number
of individual progeny are pooled and sequenced. This method has
allowed the successful mutation identification of a handful of
mutants in flies, worms, zebrafish, and mice, but the number of
complementation groups that were mapped per report is limited. It
thus remains unclear how scalable this approach is or what its
success rate is when one attempts to apply WGS to identify their
mutant of interest (Doitsidou et al. 2010; Earley and Jones 2011;
Andrews et al. 2012; Leshchiner et al. 2012; Bull et al. 2013; Henke
et al. 2013). The drawback of combining meiotic mapping and
WGS is that (1) recombination mapping requires several generations of back-crossing and is less straightforward when recessive
lethal mutations are being mapped, and (2) in order to sequence
multiple animals per genotype, animals are typically pooled and
sequenced on one lane of the Illumina sequencer at a low coverage
(43–53), which fails to identify many SNVs that are present in
the genome. In addition, it was recently found that, apart from
slightly reducing the mutational load, outcrossing mutant strains
to wild-type strains also introduces a significant number of variants and may hence complicate mutation identification (Sarin
et al. 2010).
Alternatively, independent variants that are found in the
same gene can lead to gene identification when the mutants that
are part of the same complementation group and exhibit similar
phenotypes are sequenced (Sarin et al. 2008; Gonzalez et al. 2012).
However, none of the strategies used thus far have been scaled
effectively to map numerous causative mutations, and it remains
to be determined what the optimal filters are, what fraction of
mutations can be identified, and what fraction of multiple versus
single alleles can be mapped effectively using the current technologies. Finally, one needs to demonstrate without a doubt that
a mutation is causal among hundreds of mutations.
Here, we describe our large-scale effort to map 394 EMS-induced
mutations. We performed WGS on mutant lines that were generated
in a forward genetic screen for essential genes on the X chromosome
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(Yamamoto et al. 2014) and have developed a set of filters to reduce
the number of SNVs to a manageable level. By combining WGS
with a rough mapping strategy (to ;1.4 Mb), we were able to map
274 (70%) of the mutations. The mutations were shown to be
causative by rescuing the lethality with small, molecularly defined
P[acman] duplications (Venken et al. 2009, 2010). In summary, we
show that WGS can be successfully applied to map EMS-induced
mutations on a large scale, permitting forward genetic screens to
annotate the function of numerous genes at a much greater pace
than currently available methodologies.

Results
303 sequence coverage identifies the majority of SNVs
We generated a collection of EMS-induced lethal mutations on the
Drosophila X chromosome, using low EMS concentrations (7.5–10
mM), and screened for numerous phenotypes in mosaic animals to
systematically assign phenotypes. Details of the phenotypic analysis of the screen are described elsewhere (Yamamoto et al. 2014).
We performed WGS to map the causative mutations in mutants
that displayed interesting phenotypes. About 30 virgin females
were used for genomic DNA extraction to prevent contamination
with sperm DNA, and flies were starved for 4–6 h to clear yeast
DNA. We sequenced our isogenized y w FRT19A (FRT19Aiso) at 483
coverage with Illumina HiSeq 2000 (Bentley et al. 2008) to determine the optimal coverage to detect the majority of SNVs in a
Drosophila strain when compared to the reference strain in FlyBase
(y; cn bw sp) (Adams et al. 2000; St. Pierre et al. 2013). An SNV was
considered heterozygous if it was read at least three times and
could be detected in $10% of the reads (Sarin et al. 2010). If an SNV
was detected in $90% of the reads, it was considered a homozygous SNV (Challis et al. 2012).
To identify the sequencing depth required to identify the
majority of SNVs, we randomly down-sampled FRT19Aiso reads to
simulate the number of homozygous SNVs that would be identified at specific sequencing depths (Fig. 1A). Beyond a sequencing
depth of 303, the number of identified SNVs did not effectively
increase with increased coverage (Fig. 1A). As shown in Figure 1B,
at an average of 303 coverage, ;95% of the X chromosome is sequenced at least 10 times, which represents the depth required to
reliably call heterozygous SNVs. This percentage does not include
genomic regions containing highly repetitive DNA, as it is very
difficult to properly align Illumina’s short ;100-bp reads to the
reference genome when these contain a highly repetitive sequence.
For the Drosophila X chromosome, these repetitive sequences encompass 10.3% of the chromosome, and the majority falls into
intergenic regions (Smit et al. 1996). About 3.3% of exons are
embedded in this repetitive DNA. Hence, we expect to be able to
call the SNVs with high confidence for ;92% of the exons of the X
chromosome.

Isogenized chromosomes facilitate mutation identification
As shown in Figure 1, A and C, at a sequencing depth of 483 we
identified 59,414 SNVs in FRT19Aiso, or 2.7 SNVs per kb, when
compared to the reference X chromosome in FlyBase (Adams et al.
2000; St. Pierre et al. 2013). Among these SNVs, 1844 are nonsynonymous and 16 are nonsense mutations (Fig. 1C). However,
these SNVs are most likely benign polymorphisms, as the newly
isogenized FRT19Aiso strain was extensively phenotyped prior to
mutagenesis and was selected for its robust health and fertility in

Large-scale sequencing of EMS mutations

Figure 1. A sequencing depth of 303 permits identification of 95% of SNVs. (A) Graph displaying the number of identified SNVs at different sequencing
depths for the isogenized FRT19A X chromosome (FRT19Aiso ). A 303 coverage allows identification of ;95% of the SNVs identified at 503 coverage.
(B) Percentage of the X chromosome that is covered 13–53 (black), 53–103 (dark gray), 103–203 (gray), or $203 (light gray) at various average
sequencing depths. An average sequencing depth of 303 allows reliable heterozygous SNV-calling (requiring 10 or more reads) of 95% of the X chromosome. (C ) Description of SNVs identified in the X chromosome of FRT19Aiso sequenced at 483 when compared to the reference sequence (y; cn bw sp)
(Adams et al. 2000).

homozygous flies (Yamamoto et al. 2014). Given the high genetic
diversity between these two strains, extensive filtering is required
to identify potential causative mutations in mutant lines.

Identifying candidate mutations requires multiple layers
of filtering
For mutations that cause lethality, collecting sufficient DNA to
perform WGS from hemizygous mutant animals before they die is
tedious. Therefore, we initially crossed different mutant chromosomes [y w (*) FRT19A] to FRT19Aiso and performed WGS on
heterozygous females carrying one mutant y w (*) FRT19A and one
nonmutagenized y w FRT19Aiso X chromosome to identify the
causative mutations. In a pilot experiment of four y w (*) FRT19A/y w
FRT19iso, we observed an average of 50,167 SNVs on the X chromosome when compared to the reference genome (Fig. 2B). The
majority of these SNVs correspond to variants detected in FRT19Aiso
and are therefore not causative of the mutant phenotype. Removing
the SNVs that overlap between the heterozygous mutant/FRT19Aiso
and the homozygous FRT19Aiso chromosome (Fig. 2A, DIso) resulted
in an average of 3596 candidate SNVs (Fig. 2B). Removing the SNVs
that map to intergenic regions or that correspond to synonymous
changes reduced the number of SNVs to 177 (functional in Fig. 2A).
Finally, we filtered the remaining SNVs against benign variants
that had been identified as homozygous SNVs in wild-type flies

that were sequenced for the Drosophila Genetic Reference Panel
(DDGRP) (Fig. 2A; Mackay et al. 2012). The latter filter reduced the
SNVs from 177 to 87 SNVs per heterozygous mutant chromosome
(Fig. 2B).
Determining which of the remaining 87 SNVs is causative
can depend either on failure to complement preexisting mutations
or on duplication mapping. On the X chromosome, deficiency
mapping is not feasible for essential genes as males only carry
a single X chromosome. Hence, we first performed duplication
mapping to identify a duplication that can rescue lethality. We
obtained a set of 21 partially overlapping duplications that together span 93.5% of the X chromosome (Supplemental Fig. 1A).
The duplication set consists of 1- to 2-Mb duplications inserted on
the Y chromosome or an autosome or that are free-floating chromosome fragments (Fig. 3A). Many of the selected duplications
were only mapped cytologically (Lindsley and Zimm 1992). We
therefore performed array comparative genomic hybridization
(array CGH) to determine the molecular coverage of most of these
lines and were able to identify the coverage of 16 large duplications
(Supplemental Fig. 1B,C; Erickson and Spana 2006; Cook et al.
2010). All mutants, generated in the screen, were crossed to onethird of the duplication set, covering ;50% of the X chromosome
in the first round. In subsequent rounds, mutations that failed to
be rescued by any duplication in the previous round were crossed
to the next set. This allowed us to map the lethality of 72% of
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Figure 2. Filtering process to identify candidate genes in heterozygous mutants. (A) Flowchart of filters applied to identify candidate mutations in
heterozygous mutants [y w (*) FRT19A/y w FRT19Aiso]. All identified SNVs (brown) were first filtered against SNVs identified in the isogenized FRT19A X
chromosome (DIso, orange). Subsequently, only SNVs that affect the coding sequence or splice sites were retained (functional, green). Next, the
remaining SNVs were filtered against a database, containing polymorphisms found in a homozygous state in a collection of 205 viable, wild-type strains
from the Drosophila Genetic Reference Panel (DDGRP, blue). (B, left) Impact of filters, introduced in A, on the total number of SNVs identified on the X
chromosome. (Right) In a 1-Mb interval, the number of remaining candidate mutations is ;4.

mutations to a genomic region of ;1.4 Mb. Second site lethal
mutations account for ;9.5% of the failures (data not shown), and
incomplete coverage of the duplication set accounts for another
7%. The remaining 11% may be due to an enrichment of lethal
mutations in the areas that are not covered by duplications. In
addition, large duplications create unhealthy male flies that do not
always generate sufficient offspring to determine rescue (Supplemental Fig. 1A).
Since the lethality-causing mutation of interest should be
located within the region that is covered by the rescuing duplication, we were able to reduce the number of SNVs to on average four
to five per mutant (Fig. 2B). We next rescued the lethality with
P[acman] duplications, prioritizing based on the severity of the
mutation. The P[acman] X chromosome duplication kit consists
of a library of partially overlapping 80-kb constructs that span the
entire X chromosome (Venken et al. 2010). We were able to rescue
lethality and hence confirm the molecular identity of the genetic
aberrations underlying the four sequenced heterozygous mutant/
iso lines (CG17766 [R1294X], CG6189 [Q860X], CG11579 [Q84X],
and CG3794 [V124E]) (Table 1; Supplemental Table 2). No other
mutations were identified in the coding regions contained in the
;80 kb covered by the P[acman] clones. Hence, by combining
rough mapping with WGS, we were able to identify the genetic
lesion that underlies a mutant phenotype.

Mapping two mutations at once
As with most EMS screens, we expected to isolate from one to
numerous alleles per gene. To reduce the number of lines that had
to be sequenced, we determined which alleles fail to complement
each other when they were rescued by the same duplication and
belonged to the same phenotypic class (Fig. 3B). Thus far, this
allowed us to establish 109 complementation groups consisting of
multiple alleles (5.1 alleles per gene) and 935 mutant strains that
either contain single alleles or have not been assigned to a com-
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plementation group yet. To reduce the cost, we performed WGS on
females carrying two complementing mutations mapping to different duplications, thereby halving the sequencing costs (Fig. 3C).
We generated and sequenced 197 transheterozygous lines, including 258 single alleles and 136 alleles (68 3 2) of genes represented by multiple alleles.

Additional filters greatly facilitate mutation identification
Data analysis of the first 20 sequenced transheterozygous mutants
revealed that the same SNVs could be found in multiple strains,
suggesting that these alleles are present in a substantial fraction of
the genomes. These alleles should have been eliminated in the
isogenization process, but they have likely appeared in the generations after the isogenization of the chromosome. Regardless of
their origin, these variations are unlikely to be causative of lethality. We therefore built a database to exclude these backgroundspecific SNVs (DXscreen filter) (Fig. 4A). This database can be built
and modified, depending on the number of lines that are sequenced. We tested the DXscreen database based on recurring SNVs
found in either the first six, 12, 24, 48, or 96 transheterozygous
mutant flies (Fig. 4B). Applying this filter to the sequence files for all
352 chromosomes that were sequenced led to a very significant
decrease in SNVs when the data of the first 12 transheterozygous
genomes were included (Fig. 4B). We therefore decided to build our
DXscreen database based on the sequences acquired with the first
12 genomes.
Apart from these recurring SNVs, a last filter was implemented.
We observed that some genes contain multiple SNVs in the first set
of 20 sequenced genomes that could not be found in the reference
genome or FRT19Aiso (Fig. 4C). For example, SNVs in CG32580
were found in 91% of the sequenced lines and carried, on average,
22 SNVs per X chromosome. Hence, SNVs that map to these genes
are very unlikely to be causative of the phenotypes, and the corresponding genes were excluded from our analysis as they lead to

Large-scale sequencing of EMS mutations
mutations were shown to be causal
for lethality, as mutant flies carrying a
P[acman] duplication covering the gene
are viable, and no other coding SNVs
are present in the DNA covered by the
P[acman] construct (Fig. 3D). We were
able to identify and confirm a lethal mutation in 115/136 (85%) of the sequenced
pairs (Fig. 4F). This percentage includes
strains that carry second site hits (;10%).
A strain was labeled as carrying a second
site hit if it carried a mutation in the same
gene as the other sequenced allele of the
complementation group and failed to
complement this allele, yet could not be
rescued by a P[acman] duplication (see the
underlined mutations in Table 1 and Supplemental Table 2). As discussed below,
this success rate can be further improved
with better sequencing technology and
data analysis.

Sequencing single alleles
We sequenced 258 mutations in genes
that carry single alleles. Although the average number of SNVs per mutant is 29,
duplication mapping permitted us to reduce the number of SNVs to an average of
2.44 candidate mutations per mutant,
ranging from zero to nine (Fig. 4E). For
;50% of the mutations, only one of the
candidates was a nonsense mutation, and
P[acman] duplications were used to rescue
the lethality of these mutations first. We
were able to rescue lethality and confirm
Figure 3. Mapping and sequencing strategy. General strategy to map lethal mutations on the X
the molecular identity for 159/258 of the
chromosome. (A) Duplication (Dp) mapping: For every mutant, lethality was mapped to an ;1.4-Mb
single alleles, an overall efficiency of 62%
region by Dp mapping. (B) Complementation (Compl) testing: Mutations that map to the same du(Fig. 4F; Table 1; Supplemental Table 2).
plication were intercrossed to identify Compl groups. (C ) Sequencing: Whole-genome sequencing
In total, we identified and validated
(WGS) was performed on a total of 394 transheterozygous mutations (mut 1/mut 3) whose lethalities
map to a different duplication. The 394 mutations correspond to 258 single alleles and 68 comple274 mutations in 148 genes. Of these, 20
mentation groups with two alleles. (D) Validation: We used 80-kb P[acman] duplications to rescue the
were randomly selected and all were verlethality and confirm the mapping.
ified by Sanger sequencing (data not
shown). Fifty-five percent of all validated
mutations were transitions (A4G and C4T changes) (Fig. 4G).
an elevated number of false positives. In total, this filter excludes
Eight percent of the identified mutations impair splicing, and 44%
;5% of the X chromosome genes (technical in Fig. 4A,C; Suppleare nonsense mutations. Interestingly, 81 (55%) of the identified
mental Table 1).
genes are uncharacterized, and for 111 (76%) of the genes, the
Adding these two filters to the previous sets yields an average of
described mutations represent the first lethal EMS alleles that are
29 SNVs per mutant X chromosome (Fig. 4D). These SNVs are from
publicly available (Table 1; Supplemental Table 2). Hence, the
now on referred to as candidate mutations. Hence, if a mutation can
mutations that were generated through the X chromosome screen
be mapped to an ;1.4-Mb region (the average size of the duplications)
and were mapped through WGS provide a substantial expansion of
as described above, only one to two candidate mutations should
the toolkit necessary for assigning function to genes.
remain on average, which is indeed what we observed (Fig. 4E).

Sequencing of two independently generated alleles per
complementation group
For two alleles of a complementation group, we compared only the
SNVs that fall into the region to which lethality was mapped (;1.4
Mb). For most complementation groups, this led to the identification of a single gene for which both sequenced alleles carried
a different candidate mutation. Subsequently, these candidate

Discussion
Here, we report the first large-scale mapping of chemically induced
lethal mutations in a higher eukaryote. We show that WGS can be
applied on a large scale in Drosophila to identify ;70% of the
mutations, provided that SNVs are extensively filtered and rough
mapping is performed. Upon filtering out those SNVs that are in
noncoding regions and those that lead to synonymous changes,
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Table 1.

Subset of genes, identified through WGS and validated by 80-kb P[acman] dp rescue and/or complementation tests

FlyBase ID

CG number Gene symbol

P[acman]
duplication

First EMS
allele?

FBgn0027087
FBgn0030089

CG6335
CG9113

Aats-his
AP-1y

Dp(1;3)DC347
Dp(1;3)DC203

Yes
No

FBgn0017418
FBgn0000117

CG5659
CG11579

ari-1
arm

Dp(1;3)DC342
Dp(1;3)DC034

Yes
No

FBgn0011742
FBgn0030343
FBgn0000163

CG9901
CG1886
CG5055

Arp2
ATP7
baz

Dp(1;3)DC316
Dp(1;3)DC245
Dp(1;3)DC530

FBgn0000173
FBgn0000210
FBgn0030434
FBgn0263111
FBgn0015615
FBgn0026143

CG18319
CG11491
CG4400
CG1522
CG9802
CG3658

ben
br
Brms1
cac
Cap
CDC45L

FBgn0263237
FBgn0000319
FBgn0015024
FBgn0000346
FBgn0029502
FBgn0025864

CG3319
CG9012
CG2028
CG1618
CG14437
CG12737

FBgn0011576
FBgn0025641
FBgn0001624

Mutation

Conserved in
humans?
Yes
Yes

Yes
Yes
No

D160V; R213W
L133P; Splice acceptor
(9,006,195)
C136Y
S2C; Q84X; Q100X; V144E;
D171N; Q490X
W89X
R355X; G579R; V761D
Y302X

Dp(1;3)DC277
Dp(1;3)DC443
Dp(1;3)DC261
Dp(1;3)DC131
Dp(1;3)DC316
Dp(1;3)DC100

No
No
Yes
Yes
Yes
Yes

W129X; P120L
C665R
K188X; M1I and A235T
W623X
Q146X; K575X
D99V

Yes
No
Yes
Yes
Yes
Yes

Cdk7
Chc
CkIa
comt
COQ7
Crag

Dp(1;3)DC136
Dp(1;3)DC523
Dp(1;3)DC257
Dp(1;3)DC266
Dp(1;3)DC486
Dp(1;3)DC499

Yes
No
Yes
No
Yes
Yes

Yes
Yes
Yes
Yes
Yes
Yes

CG3466
CG14622
CG1725

Cyp4d2
DAAM
dlg1

Dp(1;3)DC039
Dp(1;3)DC024
Dp(1;3)DC238

Yes
Yes
No

FBgn0000520

CG2711

dwg

Dp(1;3)DC406

No

E68K; G200D; W228S
G314S; Q498X
L141M; G148S
L257Q
W90X; W118X
W1306X; splice donor
(8,488,883)
K350X
D360V
Q551X; splice donor
(11,289,826)
C363S; H411L

FBgn0029849
FBgn0001404
FBgn0023512
FBgn0029629
FBgn0260400
FBgn0030092
FBgn0000709
FBgn0000711
FBgn0004656

CG3774
CG9659
CG3806
CG8636
CG4262
CG8971
CG1484
CG2096
CG2252

Efr
egh
eIF2B-e
eIF3-S4
elav
fh
flil
flw
fs(1)h

Dp(1;3)DC152
Dp(1;3)DC046
Dp(1;3)DC034
Dp(1;3)DC046
Dp(1;3)DC008
Dp(1;3)DC501
Dp(1;3)DC379
Dp(1;3)DC224
Dp(1;3)DC184

Yes
No
Yes
Yes
Yes
Yes
No
No
No

M216K
D241N; V333E
Y534X
K216X
Q122X
S45R
A715V
K156X
K1115X

Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes

FBgn0004598
FBgn0010391

CG18734
CG2522

Fur2
Gtp-bp

Dp(1;3)DC313
Dp(1;3)DC234

Yes
Yes

Yes
Yes

FBgn0001189
FBgn0001565
FBgn0004864
FBgn0264562

CG3095
CG1666
CG1594
CG16902

hfw
Hlc
hop
Hr4

Dp(1;3)DC029
Dp(1;3)DC379
Dp(1;3)DC238
Dp(1;3)DC035

Yes
Yes
No
Yes

Splice donor (16,269,894)
V439D; splice acceptor
(11,022,824)
W348X
G58D
G175R; Q39X; D1076N
W728X; Q867X; W885X

Comment

Yes
Yes
Yes
Yes
Yes

Other alleles of this compl.
group could be rescued

Other alleles of this compl.
group could be rescued

Yes
Yes
Yes
Yes

No
Yes
Yes
Yes

Both alleles fail to compl.
dwg8

Other alleles of this compl.
group could be rescued

All three alleles fail to compl.
dHR41

For the full list, see Supplemental Table S2. For 76% of the identified genes, no preexisting lethal EMS mutations are available. Mutation characterization
is as follows: When the mutation is not underlined or bolded, the allele can be rescued by the corresponding P[acman] duplication. When the mutation is
underlined and bolded, the allele cannot be rescued by the corresponding P[acman] duplication, and the chromosome most likely carries another lethal
mutation. When the mutation is underlined, we were unable to identify a P[acman] duplication that rescued the lethal allele. The latter two categories of
alleles were mapped by performing complementation tests with preexisting lethal alleles (see Comment).

the number of SNVs is typically reduced by about 20-fold. By removing SNVs that were found as homozygous SNVs in wild-type
flies, we further reduced the SNVs by about twofold. Removing
SNVs that occur frequently reduces the SNVs by about fivefold.
Hence, by combining WGS with a rough mapping approach, we
typically identified one to three candidates. Combining these
strategies with rescue experiments using the P[acman] BAC transgenic collection allowed us to identify 274 out of 394 EMS-induced
mutations. We also provide compelling evidence that the mutations are causative, as we rescue the lethality associated with the
mutations with relatively small, molecularly defined duplications.
Currently, a collection of strains carrying P[acman] duplications
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that together span the entire chromosome is only available for the
X chromosome (Venken et al. 2010). However, the generation of
strains for the second and third chromosome is in progress (R Chen
and G Mardon, pers. comm.). It is important to emphasize that
even low doses of EMS induce, on average, 3500 SNVs per mutant
chromosome (about one SNV per 35 kb) (Fig. 2B) emphasizing the
need of rescuing the phenotypes of EMS-induced mutations.

Enhancing mapping efficiency
As described above, when multiple alleles are sequenced from
a complementation group, we were able to successfully map 85%

Large-scale sequencing of EMS mutations

Figure 4. Filtering strategy to identify candidate genes in transheterozygous (mut 1/mut 2) mutants. (A) The same filters were applied as in Figure 2,
and additional filters were added to remove SNVs identified repeatedly in multiple sequenced genomes (DXscreen [red]). A final filter was added to
exclude genes that appear to be difficult to sequence (technical [purple]). (B) Building a background-specific filter (ΔXscreen). The largest drop in SNVs is
seen when the DXscreen filter is built based on recurring SNVs found in 12 transheterozygous mutant genomes. (C ) Building a technique-specific filter
(technical). Approximately 95 genes appear difficult to sequence or analyze, since SNVs in these genes are called in nearly every sequenced genome.
Hence, these genes were excluded from analysis (see Supplemental Table 1). (D) Distribution of the number of SNVs per chromosome that were identified
in all analyzed sequence files. On average, 15 to 25 SNVs were identified for the two X chromosomes sequenced in the same reaction. (E) Distribution of
the number of identified candidate mutations in an ;1.4-Mb region to which lethality was mapped by duplication mapping. On average, one to two
candidate mutations were found per duplication. (F) Mapping efficiency. For complementation groups consisting of multiple alleles, the causative mutation could be identified in 85% of the sequenced lines, as they could be rescued by an 80-kb P[acman] construct. For single alleles, the mutation could be
validated in 62% of the sequenced lines. (G) Characteristics of the identified mutations.

of the sequenced lines. Why only 85% of the mutations? First, the
Illumina sequencing technology has several shortcomings. Due to
the relatively short sequence reads (;100 bp), highly repetitive
genomic regions are difficult to align to the genome. Such misaligned regions would lead to the calling of numerous false-positive
SNVs and are therefore generally excluded from analysis. As determined by RepeatMasker, a program designed to detect and filter

out highly repetitive regions, 3.3% of the coding region of the
Drosophila X chromosome is excluded from analysis (Smit et al.
1996). Second, we found that a subset of the X chromosome genes
(5%) contains multiple SNVs in many WGS reactions. The 100
excluded genes (Fig. 4C; Supplemental Table 1) are not significantly bigger than the average gene on the X chromosome (data
not shown), yet SNVs are observed too frequently to be causative.
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These identified variants are therefore unlikely to represent true
SNVs. Rather, we surmise that these genes represent a challenge
for the Illumina sequencing technology. Indeed, similar findings
were recently documented when human exome sequences were
analyzed, and the investigators generated similar lists of genes
and chromosome regions that should be excluded from analysis
(Fuentes Fajardo et al. 2012). These SNVs could be the result of
misalignments in low complexity regions or of duplicated genes,
paralogs, or pseudogenes. However, the underlying reason remains unclear.
Third, at 303 sequencing depth, we are unable to call SNVs
for 4.7% of the X chromosome (Fig. 1B). Fourth, all functional
predictions are based on genes annotated in FlyBase version 5.12
of the Drosophila genome, and newly annotated or unannotated
genes were not screened (St. Pierre et al. 2013). Fifth, EMS induces
small insertions and deletions (indels) in ;2.4% of the mutant
chromosomes (Cooper et al. 2008). Indeed, when indels were analyzed in 20/120 chromosomes for which we failed to identify
a causative mutation, two causative indels were identified (CG8949
[16965894DelC] and CG7280 [18741343InTG]). We therefore estimate that 1%–3% of the total number of mutations are indels.
Finally, we did not analyze mutations that affect transcriptional
regulation. Based on the above data, the fraction of regulatory
mutations among the lethal, EMS-induced mutation fractions
appears to be very small. For the sequenced alleles that are part of
a complementation group, we reached an efficiency of 85%. If we
add the genes that were not covered at 303 coverage (4.7%), the
excluded genes (3.3% + 5.0%), and the causative indels (1%–3%),
the fraction of lethality-causing regulatory mutations that is induced by EMS is very low.

Two alleles per complementation group facilitate mutation
identification
We obtained a different mapping efficiency for complementation groups consisting of single (62%) or multiple (85%) alleles.
The reasons for this discrepancy are twofold. First, comparing
two sequence files and probing for variants that affect the same
gene is straightforward and has a higher chance of success. Second, when multiple alleles are available, it is possible to determine whether a second site lethal mutation is present on the
chromosome. Indeed, we were unable to rescue ;10% of the
mutations that are part of a complementation group using a
P[acman] construct, although the lethality associated with another allele of the same complementation group can be rescued
(Table 1; Supplemental Table 2). We therefore surmise that ;10%
of the single alleles contain a second site lethal mutation. As the
EMS dosage determines the number of induced mutations, it is
important to treat the animals with the lowest possible dose, as
this will facilitate mapping (i.e., reduce the number of candidate
SNVs) in addition to reducing the mutagenic load. Obviously, this
requires that the screening assay is simple as the number of animals
that need to be screened is inversely proportional to the dose of
EMS.

Mutation identification with WGS: What is feasible?
Numerous mutagenesis screens have been performed since the
introduction of Drosophila as a model organism (St. Johnston
2002). These screens have been very successful at describing gene
function, yet the majority of mutations are unassigned to a gene.
In the absence of any mapping or preexisting complementation
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test, it will be highly unlikely that one can identify the causative
mutation. However, when two alleles of a single complementation
group are available and our set of filters is applied, the number of
genes containing an SNV on both X chromosomes is 1.7 6 0.8
SNVs (Supplemental Fig. 2A), permitting rapid gene identification
without the need of rough mapping. Unfortunately, for screens
that were performed in the past, the isogenized strain may no
longer be available, and several filters that we used will not be
available when only two or fewer alleles are sequenced. In addition, one may be interested in mapping only a single complementation group rather than the hundreds that were sequenced
for this project. Is it possible to use WGS to identify the underlying
genetic aberrations in these mutant strains? To address this
question, we simulated the mapping for 40 different complementation groups using filters that do not require any preexisting
knowledge (Supplemental Fig. 2B). We first eliminated all the
SNVs shared by the two chromosomes, the background-specific
SNVs (background) (Supplemental Fig. 2B). Second, we applied
the functional filter to retain only the SNVs that alter the protein
coding sequence or that affect splicing. Third, we filtered out
genes that contained three or more mutations in the same gene,
which corresponded mostly to genes excluded in the technical
filter described above. For the last filter, we calculated the genome
mappability score (GMS), which represents the probability that
a read can be aligned properly at a given position (Lee and Schatz
2012), as genes that have a low mappability score are more likely
to be misaligned. For genes on the X chromosome, the average
GMS is 96 6 13 (a score of 100 represents a perfect chance of
aligning to the correct position in the genome), and we excluded
genes with a mappability score below 85, the technical filter.
Applying this set of filters yielded an average of 3.5 6 1.5 SNVs
per X chromosome that affect the same gene in both alleles of
a complementation group (Supplemental Fig. 2), including the
gene we identified previously. It should therefore be feasible to
map mutations from preexisting mutant collections using WGS
as long as two alleles or more of a complementation group are
available.
Extrapolation of our data suggests that if a behavioral
screen is performed, WGS should be able to identify the genes of
interest if the following conditions are met: First, the screen is
performed on an isogenized chromosome; second, the screened
phenotype needs to be robust such that it can be unambiguously mapped to large deficiencies or duplications by
complementation tests; and third, two or more alleles have
been identified for a given complementation group. If these
conditions are met, one can generate and apply filters (Supplemental Fig. 2B, right) that will lead to the identification of an
average of 3.5 candidate mutations. The mutants can then be
crossed to flies containing an 80-kb P[acman] construct that spans
the variant of interest. To allow this on the second and third chromosome, a collection of strains carrying 80-kb P[acman] constructs
is generated (R Chen and G Mardon, pers. comm.). As some behavioral phenotypes are extremely sensitive to alterations in the
genetic background, mapping the lesion with deficiencies may be
difficult or impossible. We estimate that for this type of mutants,
the number of remaining candidate mutations upon filtering will
be about 20-fold higher than estimated in Supplemental Figure 2B.
In summary, mapping will only be possible if the phenotypes are
not easily subject to genetic variation and if multiple alleles are
available.
To facilitate data analysis of WGS, we have established a webbased interactive tool where sequence files can be uploaded and
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filtered according to our protocol (http://www.iipl.fudan.edu.cn/
FlyVar). Here, individual filters can be selected, allowing one to, for
instance, solely filter out the SNVs that were found as a homozygous variant in the DGRP collection. In addition, we assembled
a file (Bellen-FRT19Aiso-variants.vcf) containing all SNVs that
were identified in our isogenized FRT19A strain upon filtering with
the DGRP filter (Supplemental File 1). Finally, we generated a file
(Bellen-EMS-mutations.vcf) that contains all variants, identified in
the sequenced mutants, remaining upon filtering against the DGRP
variants (Supplemental File 2). Both files can be downloaded from
http://www.iipl.fudan.edu.cn/FlyVar/sourcefordownloading.jsp.
In conclusion, given the high number of SNVs between two
Drosophila chromosomes, it is imperative to initiate a screen with
an isogenized chromosome, since more than 50,000 SNVs can be
filtered out (Fig. 2B). Next, a low dose of mutagen will facilitate the
mapping process. It reduces the generation of second site hits that
increase the total number of SNVs that potentially modify the
phenotype of interest and confound mapping efforts. Hence, an
isogenized strain that is treated with a low dose of EMS will greatly
facilitate the mapping process. Upon screening for a phenotype of
interest, the remaining mutants should be mapped to ;1 Mb. For
the X chromosome, this is most easily achieved with duplication
mapping as sets of duplications are available (Cook et al. 2010;
Venken et al. 2010). For autosomes, we recommend P-element
mapping, as it is arguably the fastest, cheapest, and least laborintensive technique to map to an ;1-Mb interval in our laboratory
(Zhai et al. 2003). Alternatively, SNP mapping (Berger et al. 2001;
Hoskins et al. 2001) or deficiency mapping (Parks et al. 2004; Cook
et al. 2012) can be used. Finally, the information obtained from
WGS with the appropriate filters described here can be combined
with the rough mapping data (Supplemental Fig. 3), resulting in
the identification of one to five candidate mutations. This number
is then reduced to a single gene by complementation tests with
small deficiencies on the autosomes or P[acman] duplications on
the X chromosome. This should allow for the relatively fast identification of the majority of mutations generated by forward mutagenesis screens and should significantly alleviate the biggest
burden of this type of screen.

Methods
EMS mutagenesis
In short, mutagenesis was performed on 6-d-old, isogenized y w
FRT19A iso males that were starved for 6–12 h by feeding them
a sucrose solution containing a low concentration (7.5–10 mM) of
EMS for 15 h. After recovery from mutagenesis, these males were
mated en masse with Df(1)JA27/FM7c Kr > GFP virgin females for
3 d. In the F1 generation, y w mut* FRT19A/FM7c Kr>GFP (mut*
indicates the EMS-induced mutation) virgins were collected and
33,887 females were crossed with FM7c Kr>GFP males to establish
balanced stocks; 5859 lines carried lethal mutations, and the
remaining stocks were discarded.

Array CGH
Array CGH to determine the molecular coverage of large cytologically mapped duplications was performed as previously described
(Erickson and Spana 2006). In brief, male flies that carry X duplications were crossed with virgin females carrying a wild-type
X chromosome. The male progeny carrying the X chromosome
duplication was selected based on the markers present on the
duplication, and genomic DNA was extracted using the PureLink

Genomic DNA mini kit (Invitrogen). Labeling, hybridization, and
detection were performed at the Duke University Microarray
Facility using operon array-ready 70mer oligo arrays. Array CGH
data for Dp(5678) were kindly provided by Drs. Eric Spana (Duke
University) and Kevin Cook (Indiana University). Data for Dp5459
were kindly provided by Dr. Ela Serpe (NICHD). We did not perform array CGH for Dp(761), Dp5594, Dp948, Dp929, and Dp5273
due to technical reasons.

Duplication rescue and rough mapping using large duplications
Virgin females from mutant lines were crossed to males carrying
different X chromosome duplications. Progenies were scored to
determine whether the duplication rescued the lethality of the
mutation. The duplication mapping was performed in three
rounds.
Round 1: Df(1)svr, Nspl-1 ras2 fw1/Dp(1;Y)y267g19.1/C(1)DX, y1 f1
(Dp901), Df(1)64c18, g1 sd1/Dp(1;2;Y)w+/C(1)DX, y1 w1 f1
(Dp936), Df(1)JC70/Dp(1;Y)dx + 5, y+/C(1)M5 (Dp5279), Dp(1;
Y )619, y+ BS/w1 oc9/C(1)DX, y1 f1 (Dp5678), y1 nejQ7 v1 f1/
Dp(1;Y )FF1, y+/C(1)DX, y1 w1 f1 (Dp5292), Df(1)v-N48, f*/
Dp(1;Y)y + v + #3/C(1)DX, y1 f1 (Dp3560), Dp(1;Y)BSC1, y+/w67c23
P{lacW}SmrG0060/C(1)RA, y1 (Dp5596), Dp(1;Y)W73, y31d B1, f+,
BS/C(1)DX, y1 f1/y1 bazEH171 (Dp1537), Dp1538, Df(1)R20, y1/
C(1)DX, y1 w1 f1/Dp(1;Y)y + mal + (Dp3033)
Round 2: Dp(1;f)R, y+/y1 dor8 (Dp761), Df(1)dhd81, w1118/C(1)DX,
y1 f1; Dp(1;2)4FRDup/+ (Dp5594), Df(1)ct-J4, In(1)dl-49, f1/
C(1)DX, y1 w1 f1; Dp(1;3)sn13a1/+ (Dp948), winscy/Dp(1;Y)8-288A/C(1)DX, y1 w1 f1 (Dp8-28-8A) (gift from Dr. Kevin Cook,
Indiana University), Df(1)v-L15, y1/C(1)DX, y1 w1 f1; Dp(1;2)v+75d/+
(Dp929), C(1;Y)6, y1 w* P{white-un4}BE1305 mew023/C(1)RM, y1 pn1
v1; Dp(1;f)y+ (Dp5459), w* l(1)dd4xr16/ FM7a/Dp(1;Y)y + g +
(Dp26276), Df(1)19, f1/C(1)DX, y1 w1 f1; Dp(1;4)r + l (Dp5273)
Round 3: Dp(1;Y)BSC231, y+ P{39.RS5 + 3.39}BSC27, BS/Df(1)ED7265,
w1118 P{39.RS5 + 3.39}ED7265/C(1)RA, In(1)scJ1, In(1)sc8, l(1)1Ac1,
scJ1 sc8 (Dp33250), Dp(1;Y)BSC223, y+ P{39.RS5 + 3.39}BSC16,
BS/Df(1)ED7344, w1118 P{39.RS5 + 3.39}ED7344/ C(1)RA,
In(1)scJ1, In(1)sc8, l(1)1Ac1, scJ1 sc8 (Dp33244), Dp(1;Y)BSC129,
y+ P{39.RS5 + 3.39}BSC22, BS/Df(1)ED7441, w1118 P{39.RS5 +
3.39}ED7441/C(1)RA, In(1)scJ1, In(1)sc8, l(1)1Ac1, scJ1 sc8
(Dp30450)
Rescued males were crossed to a stock that carries a compound
X chromosome (C(1)DX) or to the original mutant stock to establish stocks that stably produce rescued male flies. For Dp5459,
this was not possible due to technical reasons.

DNA preparation for Illumina sequencing
Twenty to 50 flies were collected, starved for 4–6 h, and frozen at
80°C. Subsequently, flies were homogenized in Buffer G2 (20 mM
EDTA, 100 mM NaCl, 1% Triton X-100, 500 mM guanidine-HCl,
10 mM Tris at pH 7.9). DNase-free RNase A was added (20 mg/mL),
and lysates were incubated for 30 min at 37°C. Samples were
subsequently subjected to proteinase K treatment (0.8 mg/mL) for
2 h at 50°C. Lysates were spun at 14,000 rpm for 20 min before
loading to pre-equilibrated Qiagen G-20 columns. Next, a standard
DNA purification protocol was followed to obtain DNA.
DNA libraries for sequencing were generated according to
Illumina’s sample preparation protocol for genomic DNA. Briefly,
1 mg of genomic DNA was sheared into 300- to 500-bp fragments.
DNA fragments were end-repaired using polynucleotide kinase
and Klenow. The 59 ends of the DNA fragments were phosphorylated and a single adenine base was added to the 39 ends using
Klenow exonuclease. Illumina Y-shaped index adaptors were
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ligated to the repaired ends,
then the DNA fragments were
PCR-amplified for eight cycles
and fragments of 200–500 bp
were isolated by bead purification. The libraries were quantified using the PicoGreen
fluorescence assay and their
size distributions determined by
the Agilent 2100 Bioanalyzer.
Libraries were sequenced on
the Illumina HiSeq 2000 as
100-bp paired-end reads (or
50-bp single-end reads for
a small number of samples),
following the manufacturer’s
protocols.

Illumina data analysis
and variant detection

Table 2. Primer pairs for PCR verification of causative mutations
CG9012 (G314S)
CG8184 (T1107I)
CG3095
CG3704 (E300X)
CG9056 (R990X)
CG10260 (W879X)
CG9045 (splice donor
mutation at 15749822)
CG9659 (V333E)
CG2845 (E595K)
CG3073 (Q190X)
CG9126 (V279D)
CG2845 (K140X)
CG11156 (Q525X)
CG4542 (W350R)
CG1424 (V216E)
CG9659 (D241N)
CG34401 (W946X)
CG6335 (D160V)
CG3039 (V93E)
CG11092 (K239X)

Repetitive sequences, present
in the D. melanogaster reference genome (dm3), were first masked
using the RepeatMasker software (Smit et al. 1996). Sequence reads
were then aligned to this masked reference genome (dm3) using
Burrows-Wheeler Aligner software (BWA version 0.5.4) (Li and
Durbin 2009) and calibrated with the Genome Analysis Toolkit
(GATK version 1.0.3299) (McKenna et al. 2010). Variants (SNVs
and small indels) were called using the Atlas2 variant analysis software (Challis et al. 2012). At least three reads were required
to support variant calling (Sarin et al. 2010). In addition to variant
calls, the application collects coverage information to estimate the
likely genotype of each variant site. For heterozygous sites, the
cutoff was set at 0.1 of the allele fraction, whereas it was set at 0.9
for homozygous sites.

ctgcagaacggtgttgatgt
cgccgaatatacacccatct
tcttttcagtggcaacatgc
tgttcctgctgcagtttgtc
cagttgccttgctgttgaaa
ctgtgtcgtaatgggcttca
gtcagcgagttgctcagatg

ctgttctgctttgcagttcg
gccagcagggatttgatgta
ttgtggtaggtgggattggt
aagattctcgaaagcgtgga
agcgatgggcacagtatctc
gctcgagaagcaccagaatc
ccgtcatatcgcccattaag

gcatttccaaggcatttgtt
ttttgcacgaggatctttcc
gccaacgtagacgaaccact
ccagcgggtaccagtttcta
actttggttcttgcccacag
aactggatgacgccgaatac
gccggagttttgaaggtaca
gcaaacagttgggtggactt
gagaattcggtgcgtggtat
ttcacctcatctcgcagcta
ccacagaagcctacaatttgc
ggaagaaaagcacgaagcac
cacgtggtccaagactcctt

tggtgacccacgaatagaca
gcagcatgttctccagcata
gcactcgtgctctcaatcaa
ggaagctatctttggcaagc
gcacatatccggcgttagtt
atccatttgggtggaacttg
aaaagggtgggcctgttagt
tgcgcgacttcagattattg
aaatgcctgcgatttctcat
acagaaaagcgcacttggac
gatcttgttcatcgccaggt
catggcaggaaacagtttga
ggttcccgattccttgagat

Sanger sequencing validation
For PCR verification of causative mutations, DNA was isolated
from 10 to 15 third instar larvae using the PureLink Genomic DNA
mini kit (Invitrogen). PCR reaction conditions were as follows:
1 mL DNA, 1 mL primer F (10 mM), 1 mL primer R (10 mM), 2 mL 103
buffer, 0.16 mL dNTPs (25 mM each), 0.08 mL Qiagen HotStarTaq
DNA polymerase (Qiagen), and 14.76 mL milliQ water. PCR cycling
conditions in PTC-225 or DNA Engine (MJ Research) were as follows: denaturation for 10 min at 94°C; 35 cycles for 30 sec at 94°C,
for 30 sec at 60°C, and for 60 at 72°C; and post-amplification extension for 10 min at 72°C. PCR was performed with mutationspecific primers (see Table 2).

Filtering

P[acman] duplication mapping

All called variants that map to the X chromosome were subjected
to several rounds of filtering to remove noncausal polymorphisms. First, homozygous and heterozygous SNVs that had
also been detected in FRT19Aiso were removed. Next, SNVs that
map to coding regions were extracted with an in-house perl script
that also allows identification of variants that affect either
splicing or the amino acid sequence (FlyBase Release 5.12 genome annotation downloaded from UCSC http://genome.ucsc.
edu/cgi-bin/hgTrackUi?g=flyBaseGene&db=dm3) (St. Pierre et al.
2013). Only these SNVs were retained. The remaining SNVs were
compared to a database that we built based on data from the
D. melanogaster Genetic Reference Panel (Mackay et al. 2012). SNVs
that were detected at least once in a homozygous state in this data
set were considered as not essential for viability and were included
in our database. The next filter is based on a database consisting of
variants that recur in the sequenced mutant strains. Variants that
appear at least once in a homozygous state or at least four times in
a heterozygous state were included in this database. SNVs of all sequenced transheterozygous mutants were filtered against this database, which was based on the first 12 sequenced genomes. The
final filter excludes SNVs that map to genes that appear to be difficult
to sequence with the current Illumina sequencing technology. The
average number of SNVs per gene was calculated based on all
remaining variants detected in the 307 sequenced genomes. The average number of SNVs per gene, per genome was calculated. Based on
the 95% confidence interval, the top 5% outliers were incorporated in
the final filter.

Balanced mutant females [ y w (*) FRT19A/FM7c Kr>GFP] were
crossed to a transgenic male, containing an 80-kb P[acman] duplication that covers a single candidate mutation. Progenies were
scored to determine whether the duplication rescued the lethality
of the mutation. A duplication was considered to cover the causative mutation if viable, unbalanced, hemizygous, mutant males
could be detected in the progeny of this cross.
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Data access
The sequencing data for this study have been submitted to the NCBI
Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra)
under accession number PRJNA239441. We have also generated
a database that allows web-based query and data filtering of sequence files (http://www.iipl.fudan.edu.cn/FlyVar). Files containing
identified variants can be found in the Supplemental Material
(Supplemental Files 1, 2) and at http://www.iipl.fudan.edu.cn/
FlyVar/sourcefordownloading.jsp. The mutant strains have been
deposited at the Bloomington Drosophila Stock Center (http://
flystocks.bio.indiana.edu/).
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